phenyl acetate has been researched along with Bladder Diseases in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alican, I; Ercan, F; Sehirli, O; Sener, G; Toklu, H | 1 |
Bouchelouche, K; Bouchelouche, P; Hald, T; Nordling, J | 1 |
Gregory, JG; Murphy, JJ; Sansone, TC; Wein, AJ | 1 |
3 other study(ies) available for phenyl acetate and Bladder Diseases
Article | Year |
---|---|
Montelukast reduces ischaemia/reperfusion-induced bladder dysfunction and oxidant damage in the rat.
Topics: Acetates; Animals; Cyclopropanes; Female; Glutathione; Isometric Contraction; Leukotriene Antagonists; Lipid Peroxidation; Male; Muscle, Smooth; Oxidative Stress; Peroxidase; Quinolines; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Sulfides; Urinary Bladder; Urinary Bladder Diseases | 2007 |
The cysteinyl leukotriene D4 receptor antagonist montelukast for the treatment of interstitial cystitis.
Topics: Acetates; Aged; Cyclopropanes; Cystitis, Interstitial; Humans; Leukotriene Antagonists; Male; Mastocytosis; Middle Aged; Pilot Projects; Prospective Studies; Quinolines; Sulfides; Urinary Bladder Diseases | 2001 |
Bladder resistance to infection.
Topics: Acetates; Animals; Bacteriuria; Cystitis; Dogs; Enterobacter; Escherichia coli Infections; Female; Male; Methods; Proteus Infections; Radiography; Urinary Bladder; Urinary Bladder Diseases; Urinary Tract Infections | 1971 |